Pure Global
NCT06404827

The Effect of Hippotherapy Simulator in Children With Spastic Cerebral Palsy

Investıgatıon of the Effect of Hıppotherapy Sımulator on Lower Extremıty Selectıve Motor Control, Balance and Trunk Control in Chıldren Wıth Spastıc Cerebral Palsy
Hasan Kalyoncu University·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Cerebral Palsy
Drug/Device/Intervention
Horseback riding simulator
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Hasan Kalyoncu University
Location
Gaziantep, Turkey
Timeline & enrollment
Phase
N/A
Start date
May 01, 2024
End date
Dec 01, 2024
Enrollment
26 participants
Primary outcome

Gross Motor Function Classification System (GMFCS),Manuel ability classification system (MACS),Change from Baseline Selective Control Assessment of the Lower Extremity at 8 weeks,Change from Baseline Pediatric balance scale at 8 weeks,Change from Baseline Trunk Control Measurement Scale at 8 weeks,Change from Baseline Modified Ashworth Scale (MAS) at 8 weeks

Summary

The horseback riding simulator (HRS) is a dynamic robotic device that mimics the movement of
 a horse for hippotherapy purposes. HRS aims to improve the patient's balance, adaptation and
 provide postural adjustment by mimicking the rhythmic movements of the horse.
 
 This study aims to research the potential benefits of the horseback riding simulator on the
 lower extremity selective motor control, balance and trunk control in children with Cerebral
 palsy.

ICD-10 classifications
Cerebral palsyOther cerebral palsyCerebral palsy, unspecifiedDyskinetic cerebral palsyAtaxic cerebral palsy
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06404827
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06404827 through Pure Global AI's free database. This phase not specified trial is sponsored by Hasan Kalyoncu University and is currently Not yet recruiting. The study focuses on Cerebral Palsy. Target enrollment is 26 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.